Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma

Jens Bedke, Brian I. Rini, Elizabeth R. Plimack, V.P. Stus, Rustem Gafanov, Tom Waddell, D. Nosov, Frédéric Pouliot, Denis Soulières, Bohuslav Melichar, Ihor Vynnychenko, Sérgio Jobim Azevedo, Delphine Borchiellini, Raymond S. McDermott, Satoshi Tamada, Allison Martin Nguyen, Shuyan Sabrina Wan, Rodolfo F. Perini, L. Rhoda Molife, Michael B. Atkins, Thomas Powles